483 swissfillon AG Apr 2019

483 swissfillon AG Apr 2019

Amir Alavi FDA, Jamie Dion FDA$119.00 - Available Now

FDA investigators audited the swissfillon AG - Visp, Switzerland facility and issued inspectional observations (via FDA 483) on 24 Apr 2019.

Product details

  • Category: Human Drugs
  • Inspection end: 24 Apr 2019
  • Location: Visp, Switzerland
  • FEI: 3014757826
Add To Cart